Watrium has contracted 4Service’s subsidiary De 3 Stuer to operate the staff restaurant at Oslo Atrium in Bjørvika, Oslo, Norway.
23rd October 2017
Watrium has doubled its shareholding in Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer, through a private placement. For more information, see the press release from Ultimovacs (Norwegian only)....
16th October 2017
Watrium invests in Kezzler AS, a global leader in serialisation technologies.
18th September 2017
Watrium invests in Cambridge Medical Robotics Ltd, a private company developing a next-generation robotic system for universal minimal access surgery.
24th August 2017
Watrium has pre-accepted Karo Pharma’s offer of NOK 35 per share for the 4 716 282 shares held in Weifa ASA.
22nd April 2017
Watrium has contracted the entrepreneur Hent AS to build A14, a new, Watrium-owned commercial real estate property in Bjørvika in Oslo. The six-floor building will cover a total of 4,300...
30th November 2016
Watrium has sold its shares in Norwegian drone producer Prox Dynamics to American company FLIR Systems. The purchase price for 100 percent of the shares in Prox Dynamics was USD...
5th September 2016
Watrium has entered into an agreement to sell sections in Fondsbygget at Aker Brygge in Oslo to Norwegian Property. The sections comprise approximately 3,200 square meters, mainly retail space on...
19th August 2016
Watrium invests to become a shareholder of Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer. Its leading product is UV1, a therapeutic cancer vaccine directed against human telomerase. Watrium’s...
28th October 2015
Watrium invests in a 20 percent ownership share in Fornebu Gateway AS, which owns two ultra-modern office buildings at Fornebu outside Oslo. The buildings have lease contract durations of around...
